Article
Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study.
Clinical genetics - 1 Jan 2017
Suchon P, Al Frouh F, Ibrahim M, Sarlon G, Venton G, Alessi M-C, Trégouët D-A, Morange P-E
Abstract excerpt
Identifying women at risk of venous thrombosis (VT) under combined oral contraceptives (COC) is a major public health issue. The aim of this study was to investigate in COC users the impact on disease of genetic polymorphisms recently identified to associate with VT risk in the general population. Nine polymorphisms located on KNG1, F11, F5, F2, PROCR, FGG, TSPAN and SLC44A2 genes were genotyped in a sample of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
